DRAK1 activators consist of a range of chemical entities capable of modulating the function or expression of DRAK1, either directly or through an array of interconnected signaling pathways. One such activator, Resveratrol, can activate the sirtuin pathways that may have overlapping activities with DRAK1-involved cellular mechanisms. Similarly, the effect of LY294002 on PI3K modulation underlines the importance of phosphatidylinositol signaling in a broader context where DRAK1 can also be a player.
The inclusion of Rapamycin, targeting the mTOR signaling pathway, further illustrates the web of signaling cascades that can influence DRAK1. Another layer of regulation is added by chemicals such as Trichostatin A and 5-Azacytidine that emphasize the epigenetic component of cellular modulation and how DRAK1 can be situated within that context. Factors like EGF, by setting off various downstream events, show the integrated nature of cellular responses and how DRAK1 can be affected within this intricate system. Phytochemicals, such as Quercetin and Sulforaphane, with their multi-tiered effects on cell signaling, accentuate the varied ways DRAK1 can be influenced. Collectively, these chemicals exemplify the complex nature of cellular networks and how nuanced modulation can impact proteins like DRAK1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Can activate sirtuin pathways which might interlink with DRAK1-associated cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibiting PI3K can modulate signaling cascades, potentially influencing DRAK1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Targets mTOR signaling, potentially influencing DRAK1 through downstream effects. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activation of adenylate cyclase can have indirect effects on pathways linked to DRAK1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibition can lead to altered cellular activities which may involve DRAK1. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Modifies gene expression, potentially affecting DRAK1 signaling indirectly. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Can modulate NRF2 pathway which may have downstream effects influencing DRAK1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Affecting the p38 MAPK pathway can potentially modulate cellular processes linked to DRAK1. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Its influence on transcriptional modulation processes can indirectly intersect with DRAK1 pathways. | ||||||